科美诊断
(688468)
| 流通市值：30.04亿 | | | 总市值：30.04亿 |
| 流通股本：4.01亿 | | | 总股本：4.01亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 73,346,975.09 | 332,678,626.15 | 260,821,861.59 | 164,615,385.76 |
| 营业收入 | 73,346,975.09 | 332,678,626.15 | 260,821,861.59 | 164,615,385.76 |
| 二、营业总成本 | 65,406,414.51 | 291,826,607.56 | 223,690,330.27 | 143,896,966.91 |
| 营业成本 | 28,251,884.48 | 111,520,648.88 | 83,409,802.03 | 53,161,388.58 |
| 税金及附加 | 1,192,067.23 | 5,333,853.25 | 4,145,065.88 | 2,687,654.82 |
| 销售费用 | 9,957,192.47 | 60,575,790.34 | 48,904,330.59 | 31,173,715.67 |
| 管理费用 | 10,451,381.88 | 44,466,283.66 | 32,733,615.89 | 22,346,481.33 |
| 研发费用 | 17,060,876.14 | 73,310,422.51 | 56,428,488.49 | 35,683,819.95 |
| 财务费用 | -1,506,987.69 | -3,380,391.08 | -1,930,972.61 | -1,156,093.44 |
| 其中:利息费用 | 1,421,779.58 | 6,408,319.57 | 4,938,687.86 | 3,377,397.07 |
| 其中:利息收入 | 3,016,512.87 | 9,963,817.81 | 7,056,416.86 | 4,594,395.73 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -676,472.6 | 1,222,390.4 | - | - |
| 加:投资收益 | 1,649,387.71 | 8,842,921.04 | 8,354,979.98 | 5,518,494.99 |
| 资产处置收益 | 386,751.41 | 118,694.97 | 108,923.99 | 97,479.89 |
| 资产减值损失(新) | 582,624.98 | -9,758,207.52 | -4,520,051.07 | -3,287,141.59 |
| 信用减值损失(新) | 316,856.35 | -630,526.83 | -876.31 | 81,589.49 |
| 其他收益 | 369,747.11 | 9,078,915.83 | 4,908,948.17 | 4,580,079.61 |
| 四、营业利润 | 10,569,455.54 | 49,726,206.48 | 45,983,456.08 | 27,708,921.24 |
| 加:营业外收入 | 674.61 | 278,119.67 | 355,415.77 | 298,166.06 |
| 减:营业外支出 | 2,817.96 | 185,748.38 | 183,211.39 | 176,302.37 |
| 五、利润总额 | 10,567,312.19 | 49,818,577.77 | 46,155,660.46 | 27,830,784.93 |
| 减:所得税费用 | 1,606,419.34 | 5,906,059.21 | 4,592,884.44 | 3,489,954.17 |
| 六、净利润 | 8,960,892.85 | 43,912,518.56 | 41,562,776.02 | 24,340,830.76 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 8,960,892.85 | 43,912,518.56 | 41,562,776.02 | 24,340,830.76 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 8,960,892.85 | 43,912,518.56 | 41,562,776.02 | 24,340,830.76 |
| 扣除非经常损益后的净利润 | 7,594,485.61 | 26,572,639.79 | 30,523,337.53 | 15,919,014.58 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.02 | 0.11 | 0.1 | 0.06 |
| (二)稀释每股收益 | 0.02 | 0.11 | 0.1 | 0.06 |
| 九、综合收益总额 | 8,960,892.85 | 43,912,518.56 | 41,562,776.02 | 24,340,830.76 |
| 归属于母公司股东的综合收益总额 | 8,960,892.85 | 43,912,518.56 | 41,562,776.02 | 24,340,830.76 |
| 公告日期 | 2026-04-29 | 2026-04-29 | 2025-10-30 | 2025-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |